Apollomics’ $899 Million Business Combination with Maxpro Capital Acquisition Corp.

White & Case advised Apollomics Inc., while Nelson Mullins Riley & Scarborough and Harneys represented Maxpro on the deal. Apollomics Inc., a late-stage clinical biopharmaceutical company,…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now